Latest Post-chemotherapy cognitive impairment Stories
Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with chemotherapy, according to a new study published online November 25 in the Journal of the National Cancer Institute.Marianne Brydøy, M.D., of the Department of Oncology, Haukeland University Hospital, in Bergen, Norway, and colleagues conducted a cross-sectional study to...
University of Rochester study shows impact of care lingers for monthsThree quarters of cancer patients and survivors treated with chemotherapy suffer insomnia or sleep disorders that often become chronic conditions, hindering patients' ability to fully recover, according to scientists at the University of Rochester Medical Center.A study of 823 cancer patients showed they experienced sleep troubles at nearly three times the rate of the general population. The problem was more prevalent in...
Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: Randomized controlled trialSupervised exercise programs that include high and low intense cardiovascular and resistance training can help reduce fatigue in patients with cancer who are undergoing adjuvant chemotherapy or treatment for advanced disease. The exercise training also improves patients' vitality, muscular strength, aerobic capacity and emotional well-being, according to research...
Study shows deterioration in brain function following breast cancer therapy has negative effects on quality of lifeOne of the most problematic side effects of cancer treatment, chemobrain "“ a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy "“ seriously diminishes women's quality of life and daily functioning. As a result, they have to adopt a range of coping strategies to manage their...
SAN FRANCISCO, Dec. 2 /PRNewswire/ -- At a symposium today hosted by Johns Hopkins University in Baltimore, Maryland, Posit Science researchers presented the latest research in brain plasticity and how the company is translating the science into technology to improve lives. Henry Mahncke, Ph.D., and Laila Spina, Psy.D., presented evidence that cognitive intervention developed by Posit Science can facilitate neuroplasticity, the brain's ability to reorganize itself throughout life. This...
Chemo brain -- reduced cognitive abilities because of chemotherapy treatment of cancer -- can improve with computer-based training, U.S. researchers say. Lead investigator Sarah-Jane Kim said chemo brain is a well-documented phenomenon in patients with different types of cancer. The declines in processing speed and memory often diminish the confidence of patients causing them to withdraw from interactions with their family, peers or co-workers at a time when support is needed most, Kim...
SAN FRANCISCO, Oct. 24 /PRNewswire/ -- Researchers at 28th annual National Academy of Neuropsychology (NAN) Conference in New York City this weekend will present data to help physicians understand more about cognitive remediation training in breast cancer survivors affected by "Chemobrain". Chemobrain is a well documented phenomenon of patients with varying types of cancer. It is associated with reduced cognitive abilities; impairing memory, concentration, decision-making ability,...
By Eric Eyre For years, cancer patients have complained about the memory loss and attention problems they experience while undergoing chemotherapy. A new animal study from West Virginia University's School of Medicine suggests there may be a way to prevent those memory- related side effects - often called "chemo-brain." WVU researchers have discovered that injections of a powerful antioxidant called N-acetyl cysteine, or NAC, could stop memory loss caused by chemotherapy drugs, according...
To: MEDICAL EDITORS Contact: Andrea Brunais, West Virginia University Health Sciences Center News Service, +1-304-293-7087, brunaisa@wvuh.com MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNewswire/ -- Cancer patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University, researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes...
Injections of N-acetyl cysteine, an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes induce, U.S. researchers said. Rats were given the commonly used chemotherapy drugs adriamycin and cyclophosphamide and while on the drugs, rats who were trained to prefer a light room to a dark room forgot their training. "When animals are treated with chemotherapy drugs, they lose memory," Gregory Konat said in a statement. "When we add N-acetyl cysteine during...
